Atara Biotherapeutics, Inc. (ATRA)
9.76
+0.23
(+2.41%)
USD |
NASDAQ |
Sep 04, 16:00
10.34
+0.58
(+5.94%)
After-Hours: 20:00
Atara Biotherapeutics Market Cap : 92.16M for Sept. 4, 2026
Market Cap Chart
Sep '18
Jan '19
May '19
285.00
270.00
255.00
240.00
Historical Market Cap Data
| Date | Value |
|---|---|
| September 04, 2026 | 92.16M |
| September 03, 2026 | 89.99M |
| September 02, 2026 | 89.14M |
| September 01, 2026 | 85.18M |
| August 31, 2026 | 84.04M |
| August 28, 2026 | 86.88M |
| August 27, 2026 | 87.35M |
| August 26, 2026 | 88.58M |
| August 25, 2026 | 92.92M |
| August 24, 2026 | 89.33M |
| August 21, 2026 | 91.60M |
| August 20, 2026 | 88.58M |
| August 19, 2026 | 90.65M |
| August 18, 2026 | 82.34M |
| August 17, 2026 | 78.94M |
| August 14, 2026 | 76.39M |
| August 13, 2026 | 80.36M |
| August 12, 2026 | 87.11M |
| August 11, 2026 | 84.42M |
| August 10, 2026 | 81.30M |
| August 07, 2026 | 71.93M |
| August 06, 2026 | 70.22M |
| August 05, 2026 | 72.69M |
| August 04, 2026 | 74.65M |
| August 03, 2026 | 72.78M |
| Date | Value |
|---|---|
| July 31, 2026 | 71.33M |
| July 30, 2026 | 69.54M |
| July 29, 2026 | 68.61M |
| July 28, 2026 | 66.48M |
| July 27, 2026 | 65.63M |
| July 24, 2026 | 67.24M |
| July 23, 2026 | 69.54M |
| July 22, 2026 | 69.16M |
| July 21, 2026 | 73.46M |
| July 20, 2026 | 70.56M |
| July 17, 2026 | 71.42M |
| July 16, 2026 | 74.22M |
| July 15, 2026 | 72.78M |
| July 14, 2026 | 68.44M |
| July 13, 2026 | 73.80M |
| July 10, 2026 | 83.08M |
| July 09, 2026 | 84.65M |
| July 08, 2026 | 82.14M |
| July 07, 2026 | 87.33M |
| July 06, 2026 | 92.61M |
| July 02, 2026 | 99.16M |
| July 01, 2026 | 96.78M |
| June 30, 2026 | 97.72M |
| June 29, 2026 | 95.08M |
| June 26, 2026 | 89.46M |
Market Capitalization Definition
Market Capitalization measures the total value of a company based on their stock price multiplied by the shares outstanding. This metric is important because it gives you an idea of the size of a company, and how the size has changed over time. When studying companies from a relative basis, it would make sense to compare companies that have a similar market capitalization because factors like market share, economies of scale, and business models would also be similar.
Market Cap Range, Past 5 Years
--
Minimum
--
Maximum
--
Average
--
Median
Market Cap Benchmarks
| ACADIA Pharmaceuticals, Inc. | 4.823B |
| Alnylam Pharmaceuticals, Inc. | 35.59B |
| Anika Therapeutics, Inc. | 278.50M |
| Savara, Inc. | 1.103B |
| Vericel Corp. | 2.057B |
Market Cap Related Metrics
| PS Ratio | 19.70 |
| PEG Ratio | -0.0305 |
| Price | 9.76 |
| Earnings Yield | -14.33% |
| PEGY Ratio | -0.0305 |